ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hoth Therapeutics' Enrollment and Dosing in Second Cohort in Phase 1b Human Trial for Atopic Dermatitis Under Way
December 01, 2021Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs, is pleased to announce that enrollment... -
Hoth Therapeutic Submits Ethics Approval Request for Atopic Dermatitis Trial
August 18, 2020Hoth Therapeutics has submitted for ethics approval in Australia for its planned Clinical study of its therapeutic BioLexa for Atopic Dermatitis. The ethics submission was made to the Bellberry Human Research Ethics Committee in Australia. -
Hoth Signs Contract Service Pacts for BioLexa
June 19, 2019Particle Sciences, Regis Technologies called on for upcoming toxicology and clinical trials.
Pharma Sources Insight January 2025
